Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS, 66045, USA.
Department of Pharmacology and Toxicology, School of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
Adv Exp Med Biol. 2019;1173:105-123. doi: 10.1007/978-981-13-9589-5_6.
Ischemic and hemorrhagic stroke are the common types of stroke that lead to brain injury neurological deficits and mortality. All forms of stroke remain a serious health issue, and there is little successful development of drugs for treating stroke. Incomplete understanding of stroke pathophysiology is considered the main barrier that limits this research progress. Besides mitochondria and free radical-producing enzymes, labile iron is an important contributor to oxidative stress. Although iron regulation and metabolism in cerebral stroke are not fully understood, much progress has been achieved in recent years. For example, hepcidin has recently been recognized as the principal regulator of systemic iron homeostasis and a bridge between inflammation and iron regulation. This review discusses recent research progress in iron pathophysiology following cerebral stroke, focusing molecular regulation of iron metabolism and potential treatment targets.
缺血性卒中和出血性卒中等是导致脑损伤、神经功能缺损和死亡的常见类型的中风。所有类型的中风仍然是一个严重的健康问题,治疗中风的药物很少取得成功的发展。对中风病理生理学的不完全了解被认为是限制这一研究进展的主要障碍。除了线粒体和自由基产生酶之外,不稳定的铁也是氧化应激的一个重要贡献者。尽管脑卒中铁的调节和代谢还不完全清楚,但近年来已经取得了很大的进展。例如,铁调素最近被认为是全身铁稳态的主要调节剂,也是炎症和铁调节之间的桥梁。这篇综述讨论了脑卒中铁病理生理学的最新研究进展,重点是铁代谢的分子调节和潜在的治疗靶点。